Company facts
- Headquarters
- Watertown, Massachusetts
- Most recent report
- 10-Q, filed Oct 29, 2026
- Incorporated
- Delaware
- Filings on record
- 647 filings
- On EDGAR
- CIK 1815442
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 77
Prospectuses and Registrations 8 of 27
- 424B3 Prospectus supplement for an offering Feb 26, 2026
- 424B5 Prospectus supplement for an offering Feb 26, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B5 Prospectus supplement for an offering Dec 8, 2025
- 424B5 Prospectus supplement for an offering Jun 27, 2025
- 424B5 Prospectus supplement for an offering Jun 25, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 479
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Oct 1, 2026
- 144 Notice of a proposed sale of restricted stock Oct 1, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Sep 8, 2026
- 4 Insider reported a trade Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
Other 8 of 27
- ARS Annual report sent to shareholders Apr 29, 2026
- UPLOAD Comment letter from SEC staff May 7, 2025
- CORRESP Reply to SEC staff Apr 30, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
- UPLOAD Comment letter from SEC staff Apr 25, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
- ARS Annual report sent to shareholders Apr 27, 2023
- EFFECT Notice that a registration became effective Jun 30, 2021
Everything here comes from Kymera Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.